Bausch + Lomb Corporation (TSX: BLCO)
Market Cap | 9.56B |
Revenue (ttm) | 6.33B |
Net Income (ttm) | -497.15M |
Shares Out | n/a |
EPS (ttm) | -1.41 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 1,617 |
Open | 27.25 |
Previous Close | 27.31 |
Day's Range | 27.05 - 27.25 |
52-Week Range | 18.11 - 29.37 |
Beta | 0.48 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Oct 31, 2024 |
About Bausch + Lomb
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and ... [Read more]
News
Bausch + Lomb Corporation (BLCO) Q3 2024 Earnings Call Transcript
Bausch + Lomb Corporation (NYSE:BLCO) Q3 2024 Results Conference Call October 30, 2024 8:00 AM ET Company Participants George Gadkowski - Vice President of Investor Relations and Business Insights Br...
Bausch + Lomb Stock Pops as TPG, Blackstone Consider Joint Bid
Bausch + Lomb Corporation (BLCO) shares popped Monday morning following reports Blackstone (BX) and TPG (TPG) are considering teaming up to buy the eyecare company.
Overlooked Stock: BLCO
Bausch + Lomb (BLCO) closed on a 52-week high following reports of the company planning to sell itself. George Tsilis explains why this led to a rally for the medical services company.
Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues
Bausch + Lomb Corp (NYSE: BLCO) is reportedly considering a sale as it navigates separation issues from its parent company, Bausch Health Companies (NYSE: BHC). The potential sale is part of efforts...
Bausch + Lomb Stock Jumps Amid Reports Of A Sale
Bausch + Lomb (BLCO) shares popped Monday following a report that the eyecare company is considering a sale.
Bausch + Lomb Soars on Report That It’s Exploring a Sale
Bausch + Lomb Corp. shares rose the most ever following a report that the eye-care company is considering selling itself to disentangle from its debt-laden parent company.
Bausch + Lomb Corporation (BLCO) Q2 2024 Earnings Call Transcript
Bausch + Lomb Corporation (NYSE:BLCO) Q2 2024 Earnings Call July 31, 2024 8:00 AM ET Company Participants George Gadkowski - Vice President, Investor Relations Brent Saunders - Chairman and Chief Exe...
Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentati...
Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. intro...
Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launc...
Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live bet...
Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry's Meeting®
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentati...
Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Health Ca...
Bausch + Lomb Corporation (BLCO) Q1 2024 Earnings Call Transcript
Bausch + Lomb Corporation (NYSE:BLCO) Q1 2024 Earnings Conference Call May 1, 2024 8:00 AM ET Company Participants George Gadkowski - VP, IR & Business Insights Brent Saunders - Chairman & CEO Sam El...
Bausch + Lomb Announces First-Quarter 2024 Results
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its first-quar...
Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentati...
Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Frontiers in O...
Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programs
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its ONE by ONE...
Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter...
Bausch + Lomb Stock Jumps After Better-Than-Expected Earnings, Guidance (Investopedia)
A big jump in pharmaceutical sales helped eye-care products maker Bausch + Lomb Corp. beat profit and sales estimates for the fourth quarter.
Bausch + Lomb Corporation (BLCO) Q4 2023 Earnings Call Transcript
Bausch + Lomb Corporation (BLCO) Q4 2023 Earnings Call Transcript
Eye Care-Focused Bausch + Lomb's Stock Surges On Upbeat Annual Guidance Despite Deeper Losses
Bausch + Lomb Corp (NYSE: BLCO) reported the fourth quarter of 2023 sales of $1.173 billion, up 18% year-on-year (Y/Y), beating the consensus of $1.02 billion . Excluding the unfavorable impact of fo...
Bausch & Lomb's stock soars 11% after earnings beat
Bausch + Lomb Corp.'s stock soared 10% early Wednesday, after the vision-care company's adjusted fourth-quarter profit topped estimates and it offered upbeat revenue guidance for 2024.
Bausch + Lomb Corp at JPMorgan Healthcare Conference Transcript
Bausch + Lomb Corp at JPMorgan Healthcare Conference Transcript
Bausch + Lomb Corp at Morgan Stanley Global Healthcare Conference Transcript
Bausch + Lomb Corp at Morgan Stanley Global Healthcare Conference Transcript